NCT00703469View on ClinicalTrials.gov

A Study of MDX-1106 to Treat Patients With Hepatitis C Infection

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Hepatitis C
Interventions
DRUG

MDX1106-02

Single dose

DRUG

Placebo

Placebo single dose

Trial Locations (7)

19104

University of Pennsylvania School of Medicine, Philadelphia

21287

John Hopkins University School of Medicine, Viral Hepatitis Center, Baltimore

62701

Springfield Clinic Infectious Diseases, Springfield

75203

The Liver Institute at Methodist Dallas, Dallas

78215

Alamo Medical Research, San Antonio

92801

Advanced Clinical Resesarch Institute, Anaheim

94115

Quest Clinical Research, San Francisco

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY